In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Mounjaro® (Tirzepatide, Injectable pen) by Eli Lilly has been FDA-approved since 2022 for Type 2 diabetes. Weight Method offers a separate option for Dinuba residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month — same pricing regardless of location.
FDA-approved Mounjaro prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Dinuba is already seeing results
Mounjaro in Dinuba, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Mounjaro to patients in Dinuba from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Mounjaro® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2022. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible Dinuba, CA residents starts at $329/month.
In the suburbs of Dinuba, getting to a weight loss specialist often means a drive to a medical center and a long wait for an appointment. Weight Method eliminates that obstacle: consult with a licensed California provider from your home, receive your compounded Tirzepatide prescription (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved), and have it shipped directly at $329/month.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.